Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Neurovascular Devices Market, by End User
1.4.2 Europe Neurovascular Devices Market, by Technology
1.4.3 Europe Neurovascular Devices Market, by Disease Pathology
1.4.4 Europe Neurovascular Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Neurovascular Devices Market by End User
3.1 Europe Hospital & Surgery Centers Market by Country
3.2 Europe Ambulatory Care Centers Market by Country
3.3 Europe Research laboratories & Academic Institutes Market by Country
Chapter 4. Europe Neurovascular Devices Market by Technology
4.1 Europe Embolization & Coiling Market by Country
4.2 Europe Neurovascular Devices Market by Embolization & Coiling Type
4.2.1 Europe Embolic Coils Market by Country
4.2.2 Europe Flow Diversion Devices Market by Country
4.2.3 Europe Liquid Embolic Agents Market by Country
4.3 Europe Neurothrombectomy Devices Market by Country
4.4 Europe Neurovascular Devices Market by Neurothrombectomy Devices Type
4.4.1 Europe Clot Retrievers Market by Country
4.4.2 Europe Suction & Aspiration Devices Market by Country
4.4.3 Europe Snares Market by Country
4.5 Europe Cerebral Balloon Angioplasty & Stenting Systems Market by Country
4.6 Europe Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
4.6.1 Europe Carotid Artery Stents Market by Country
4.6.2 Europe Embolic Protection Systems Market by Country
4.7 Europe Support Devices Market by Country
4.8 Europe Neurovascular Devices Market by Support Devices Type
4.8.1 Europe Microcatheters Market by Country
4.8.2 Europe Microguidewires Market by Country
Chapter 5. Europe Neurovascular Devices Market by Disease Pathology
5.1 Europe Cerebral Aneuryms Market by Country
5.2 Europe Ischemic Strokes Market by Country
5.3 Europe Cartoid Artery Stenosis Market by Country
5.4 Europe Arteriovenous Malformation & Fistulas (AVM) Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Neurovascular Devices Market by Country
6.1 Germany Neurovascular Devices Market
6.1.1 Germany Neurovascular Devices Market by End User
6.1.2 Germany Neurovascular Devices Market by Technology
6.1.2.1 Germany Neurovascular Devices Market by Embolization & Coiling Type
6.1.2.2 Germany Neurovascular Devices Market by Neurothrombectomy Devices Type
6.1.2.3 Germany Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.1.2.4 Germany Neurovascular Devices Market by Support Devices Type
6.1.3 Germany Neurovascular Devices Market by Disease Pathology
6.2 UK Neurovascular Devices Market
6.2.1 UK Neurovascular Devices Market by End User
6.2.2 UK Neurovascular Devices Market by Technology
6.2.2.1 UK Neurovascular Devices Market by Embolization & Coiling Type
6.2.2.2 UK Neurovascular Devices Market by Neurothrombectomy Devices Type
6.2.2.3 UK Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.2.2.4 UK Neurovascular Devices Market by Support Devices Type
6.2.3 UK Neurovascular Devices Market by Disease Pathology
6.3 France Neurovascular Devices Market
6.3.1 France Neurovascular Devices Market by End User
6.3.2 France Neurovascular Devices Market by Technology
6.3.2.1 France Neurovascular Devices Market by Embolization & Coiling Type
6.3.2.2 France Neurovascular Devices Market by Neurothrombectomy Devices Type
6.3.2.3 France Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.3.2.4 France Neurovascular Devices Market by Support Devices Type
6.3.3 France Neurovascular Devices Market by Disease Pathology
6.4 Russia Neurovascular Devices Market
6.4.1 Russia Neurovascular Devices Market by End User
6.4.2 Russia Neurovascular Devices Market by Technology
6.4.2.1 Russia Neurovascular Devices Market by Embolization & Coiling Type
6.4.2.2 Russia Neurovascular Devices Market by Neurothrombectomy Devices Type
6.4.2.3 Russia Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.4.2.4 Russia Neurovascular Devices Market by Support Devices Type
6.4.3 Russia Neurovascular Devices Market by Disease Pathology
6.5 Spain Neurovascular Devices Market
6.5.1 Spain Neurovascular Devices Market by End User
6.5.2 Spain Neurovascular Devices Market by Technology
6.5.2.1 Spain Neurovascular Devices Market by Embolization & Coiling Type
6.5.2.2 Spain Neurovascular Devices Market by Neurothrombectomy Devices Type
6.5.2.3 Spain Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.5.2.4 Spain Neurovascular Devices Market by Support Devices Type
6.5.3 Spain Neurovascular Devices Market by Disease Pathology
6.6 Italy Neurovascular Devices Market
6.6.1 Italy Neurovascular Devices Market by End User
6.6.2 Italy Neurovascular Devices Market by Technology
6.6.2.1 Italy Neurovascular Devices Market by Embolization & Coiling Type
6.6.2.2 Italy Neurovascular Devices Market by Neurothrombectomy Devices Type
6.6.2.3 Italy Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.6.2.4 Italy Neurovascular Devices Market by Support Devices Type
6.6.3 Italy Neurovascular Devices Market by Disease Pathology
6.7 Rest of Europe Neurovascular Devices Market
6.7.1 Rest of Europe Neurovascular Devices Market by End User
6.7.2 Rest of Europe Neurovascular Devices Market by Technology
6.7.2.1 Rest of Europe Neurovascular Devices Market by Embolization & Coiling Type
6.7.2.2 Rest of Europe Neurovascular Devices Market by Neurothrombectomy Devices Type
6.7.2.3 Rest of Europe Neurovascular Devices Market by Cerebral Balloon Angioplasty & Stenting Systems Type
6.7.2.4 Rest of Europe Neurovascular Devices Market by Support Devices Type
6.7.3 Rest of Europe Neurovascular Devices Market by Disease Pathology
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Johnson & Johnson
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.6 Merit Medical Systems, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 MicroPort Scientific Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Medikit Co. Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.9 W. L. Gore & Associates, Inc.
7.9.1 Company Overview
Unique Offerings 
